McKesson acquired the two companies for a combined price of $1.2 billion.
Vantage Oncology owns and operates more than 50 cancer treatment centers across the United States. Biologics focuses on cancer care alignment.
More articles on health IT:
5 recent vendor contracts, go-lives
3 ways to manage data breach exposure
Lockheed Martin expands data security responsibilities at VA
